Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PACIFICHEALTH LABORATORIES INC (PHLI)
|
Add to portfolio |
|
|
|
| Price: |
$0.00
| | Metrics |
| OS: |
20.9
|
M
| |
|
|
| Market cap: |
|
| |
-87
|
% ROIC
|
|
Net cash:
|
$219.6
|
k
| |
$0.01
|
per share
|
|
EV:
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($861.7)
|
k
| |
|
|
|
EBIT
|
($927.3)
|
k
| |
|
|
| EPS |
($0.05)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 |
| Revenues | 6.9 | 7.2 | 8.0 | 7.2 | 7.4 |
| Revenue growth | -4.0% | -9.9% | 10.5% | -2.6% | |
| Cost of goods sold | 3.9 | 4.0 | 4.8 | 4.2 | 4.9 |
| Gross profit | 3.0 | 3.2 | 3.2 | 3.0 | 2.5 |
| Gross margin | 43.2% | 43.9% | 40.3% | 41.8% | 34.2% |
| Sales and marketing | 1.3 | 1.2 | 1.9 | 0.9 | 0.9 |
| Research and development | 0.0 | 0.0 | | 0.2 | 0.2 |
| General and administrative | 2.2 | 2.8 | 3.2 | 3.5 | 2.8 |
| EBIT | -0.5 | -0.8 | -1.9 | -1.6 | -1.3 |
| EBIT margin | -6.9% | -10.6% | -23.3% | -21.7% | -18.0% |
| Pre-tax income | -0.5 | -0.8 | -1.9 | -2.0 | -1.3 |
| Income taxes | 0.0 | 0.0 | -0.3 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 13.5% | 0.0% | 0.0% |
| Net income | -0.5 | -0.8 | -1.7 | -2.0 | -1.3 |
| Net margin | -7.0% | -10.6% | -21.0% | -27.6% | -17.2% |
| |
| Diluted EPS | ($0.02) | ($0.05) | ($0.11) | ($0.15) | ($0.10) |
| Shares outstanding (diluted) | 19.5 | 16.1 | 15.0 | 13.7 | 13.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|